WHWK: Aadi Bioscience Inc Company Cash Volume

WHWK (Aadi Bioscience Inc) - company brandmark

The development of Aadi Bioscience Inc (WHWK) relies on insurance coverage and sales of rare tumor therapies. The current cash balance demonstrates the pace of financial recovery, where the value of 0.17 serves as the current indicator. Aadi Bioscience Inc maintains a monopoly in the sarcoma niche due to patents and FDA status. Meanwhile, operations comply with basic environmental safety standards in laboratories.

Company Cash Reserve: aadibio.com (WHWK) for 03/20/2025 - 11/21/2026

Metric breakdowns and analytics for Aadi Bioscience Inc (WHWK)

- stock quotes and analyst forecast:
- cash and cash flow statistics:
Basic company analysis:Aadi Bioscience
Brand item of Aadi Bio

Stable demand for oncology therapies renders the business of Aadi Bioscience Inc. (WHWK) insensitive to market cycles, shifting the primary risks into the realm of scientific research. Analyzing changes in cash balances allows for an assessment of the liquidity available to fund development, where a sufficient reserve confirms solvency, while excessive passive cash during inflationary periods leads to the hidden depreciation of the company's assets.

Competitors of Aadi Bioscience Inc (WHWK)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds